18F-AV-1451 High Resolution Autopsy Study

• Status: Completed
• Trial end date: 2018-05-18
• Target enrollment: 0
• Participant gender: All

Summary

The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Avid Radiopharmaceuticals

Criteria

Inclusion Criteria:

• Projected life expectancy ≤ 6 months

Exclusion Criteria:

• Primary brain tumor, known metastases to the brain, central nervous system lymphoma

• Major, focal structural brain lesion

• Aggressively being treated with life sustaining measures

• Clinically significant infectious disease

• History of risk factors for Torsades de Pointes or are currently taking medication known to cause QT prolongation

• Have received or participated in a trial with investigational medications in the past 30 days

• Females of childbearing potential who are pregnant or not using adequate contraception